Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A children's oncology group phase I consortium study

Lars M. Wagner, John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, Peter C. Adamson

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A children's oncology group phase I consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences